considering they are looking to establish penetration into the markets around the world, and also go with a “Nespresso machine” type approach to this biotech, initial sales of the machinery will likely come at a cost IMO.
In the early stages it will be much more about increasing revenues, and increasing market uptake...... thinking about short term profit for such volumes of sale is probably not the company’s strategy
Ann: FELIX verification and validation update, page-13
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5790554 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2706897 | 3 |
View Market Depth
| Last trade - 16.12pm 05/07/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable